BIOL recovery flag breakout $1.57 Nasdaq CM We
Post# of 98045
Nasdaq CM
Website
Shares Outstanding 58.26M
Float 32.36M
% Held by Insiders 21.92%
% Held by Institutions 1 47.60%
Shares Short 2.59M
Short Ratio 53.65
Short % of Float 6.77%
Shares Short (prior month) 32.57M
BIOLASE, Inc.,a medical device company, develops, manufactures, and markets laser systems in dentistry and medicine in the Unites States and internationally. It offers Waterlase dental laser systems for cutting soft and hard tissue; and diode laser systems, which are used in soft tissue, pain therapy, and cosmetic procedures, such as teeth whitening. The companys dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of dental procedures, including cosmetic, restorative, and complex surgical applications. It also markets and distributes dental imaging equipment, including cone beam digital X-rays and CAD/CAM intra-oral scanners, and in-office, chair-side milling machines and three-dimensional (3-D) printers. The companys dental imaging products comprise 3Shape Trios CAD/CAM digital impression systems for high-speed digital 3-D picture taking; and Galaxy BioMill CAD/CAM system that enables dental practitioners to complete scanning, designing, milling, and finishing of crowns, inlays, and veneers in the dental office. In addition, it manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces. The company sells its products primarily to dentists in general practice through its direct sales force and distributor network. BIOLASE, Inc. has a strategic agreement with Valam, Inc. to develop, market, and sell office-based laser systems to otolaryngologists. BIOLASE, Inc. was founded in 1984 and is headquartered in Irvine, California.